2型糖尿病患者对疾病进展的恐惧状况探讨及影响因素分析

Exploration of Fear of Disease Progression in Type 2 Diabetes Mellitus Patients and Analysis of Influencing Factors

目的 调查2型糖尿病患者对疾病进展的恐惧(fear of progression, FoP)状况并探讨其影响因素。方法 采用方便抽样,选取2021年9月—2023年3月青岛市市立医院内分泌科住院的375例2型糖尿病患者为研究对象,应用一般资料调查表、社会支持量表、恐惧疾病进展简化量表、简易疾病感知量表进行调查。结果 2型糖尿病患者恐惧疾病进展简化量表得分为(32.73±9.77)分,处于中度水平,心理失调(FoP≥34分)的患者比例为46.1%。多重线性回归分析结果表明,疾病感知、医疗负担情况、治疗方式种类、健康信息来源、客观支持、并发症数量是2型糖尿病患者恐惧疾病进展的影响因素(P<0.05),能解释2型糖尿病患者疾病进展恐惧心理35.7%的变异度。结论 对于2型糖尿病患者,临床医护人员应重视患者的恐惧心理状态,通过关注患者疾病感知等预测因子,适度调控患者对疾病进展的恐惧状况,更大发挥其心理内驱力作用,降低产生心理失调患者的恐惧水平。

Objective To investigate the Fear of Progression(FoP)status of type 2 diabetes mellitus patients and explore its influencing factors.Methods Using convenience sampling,375 cases of type 2 diabetes mellitus patients hospitalized in the Department of Endocrinology of Qingdao Municipal Hospital were investigated from September 2021 to March 2023 as the research object with the application of the General Information Questionnaire,Social Support Scale,Fear of Progression Simplified Scale,and Simple Disease Perception Scale.Results The FoP-Q-SF score of type 2 diabetes mellitus patients was(32.73±9.77)points,which was at a moderate level,and the proportion of patients with psychological disorders(FoP≥34)was 46.1%.The results of multiple linear regression analysis showed that disease perception,healthcare burden situation,type of treatment,source of health information,objective support,and number of complications were the factors influencing the fear of disease progression in patients with type 2 diabetes mellitus(P<0.05),which explains 35.7%of the variation in the fear of disease progression in patients with type 2 diabetes mellitus.Conclusion For patients with type 2 diabetes mellitus,clinical staff should pay attention to the patients'fear psychological state,by paying attention to the patients'disease perception and other predictive factors,moderately regulate the patients'fear of disease progression,play a greater role in their psychological internal drive,and reduce the level of fear in patients with psychological disorders.